scholarly journals Marine Bioactives: Pharmacological Properties and Potential Applications against Inflammatory Diseases

Marine Drugs ◽  
2012 ◽  
Vol 10 (12) ◽  
pp. 812-833 ◽  
Author(s):  
Nicolantonio D’Orazio ◽  
Maria Alessandra Gammone ◽  
Eugenio Gemello ◽  
Massimo De Girolamo ◽  
Salvatore Cusenza ◽  
...  
2020 ◽  
pp. 83-115
Author(s):  
Muneeb U Rehman ◽  
Sheikh Bilal Ahmad ◽  
Aazima Shah ◽  
Bismah Kashani ◽  
Anas Ahmad ◽  
...  

2016 ◽  
Author(s):  
Αικατερίνη Νικολάου

Phospholipases A2 (PLA2) are enzymes that hydrolyze the sn-2 ester bond of phospholipids releasing free fatty acids and lysophospholipids. Among them, arachidonic acid can be converted into a variety of eicosanoids by metabolic enzymes, while lysophosphatidylcholine (LPC), the most abundant lysophospholipid in plasma and tissues, can be converted into lysophosphatidic acid (LPA) by a secreted enzyme that exhibits lysophospholipase D activity, known as autotaxin (ATX). Both enzymes are involved in inflammatory conditions and, as a consequence, constitute attractive targets for the development of novel agents for the treatment of inflammatory diseases. Due to the fact that molecules which bear the 2-oxoamide functional group and long aliphatic chains exhibit inhibitory activity against cytosolic GIVA cPLA2, 2-oxoamideswith reduced lipophilicity were designed and synthesized. Taking into consideration that in recent years hydroxamic acids have attracted considerable attention due to their pharmacological properties, hydroxamic acids and derivatives there of were designed and synthesized, so as to evaluate their inhibitory activity against ATX.


2021 ◽  
pp. 131380
Author(s):  
Yan Zhang ◽  
Ying-Fan Hu ◽  
Wei Li ◽  
Guang-Ya Xu ◽  
Kun-Rong Wang ◽  
...  

PET Clinics ◽  
2020 ◽  
Vol 15 (4) ◽  
pp. 547-558
Author(s):  
Sanaz Katal ◽  
Ali Gholamrezanezhad ◽  
Moozhan Nikpanah ◽  
Thomas Q. Christensen ◽  
Thomas J. Werner ◽  
...  

2020 ◽  
Vol 10 (3) ◽  
pp. 243-258
Author(s):  
Igor V. Kuzmin ◽  
Sergey Yu. Borovets ◽  
Anatoliy G. Gorbachev ◽  
Salman Kh. Al-Shukri

The review summarizes the results of 30-year clinical application of the prostatic bioregulatory peptide Prostatilen. The data from experimental studies, testifying for the high biological activity of the drug is shown, the mechanisms of its therapeutic action are described. The review presents the results of clinical studies demonstrating the effectiveness and pathogenetic justification of the prescription of Prostatilen in the treatment of chronic prostatitis, benign prostatic hyperplasia, infectious and inflammatory diseases of the kidneys and urinary bladder, as well as of several other diseases. The experience of Prostatilen application in the urological clinic of First Pavlov Saint Petersburg State Medical University is shown.


1998 ◽  
Vol 11 (1) ◽  
pp. 28-37
Author(s):  
Joseph A. Tami

Since the discovery of the structure and function of DNA over 40 years ago, the established knowledge of molecular biology has increased dramatically, and many new tools have been discovered and utilized by scientists to develop new therapeutic agents. Important tools that are used in recombinant DNA technology include restriction endonucleases (cleave DNA), DNA ligase (link DNA molecules together), and cloning vectors (place foreign DNA into an organism such as bacterial or yeast cells in order to mass produce the protein encoded by that foreign DNA). The development of hybridoma technology provided a method to produce virtually unlimited quantities of pure antibody with a single specificity. These immuno-globulins are known as monoclonal antibodies, and have provided both therapeutic and diagnostic agents. Antisense molecules are oligonucleotides which bind to the messenger RNA (mRNA) of a target gene and selectively inhibit the production of specific proteins. Potential applications for these molecules include cancer and viral and inflammatory diseases. The more recent development of the polymerase chain reaction (PCR) has provided a tool that has revolutionized diagnostic testing in diverse areas such as infectious diseases, genetic abnormalities, and cancer.


Author(s):  
Valeria Cavalloro ◽  
Francesco Bracco ◽  
Simona Collina ◽  
Emanuela Martino

: Prunus lycioides (Spach) C.K. Schneid. (= Amygdalus lycioides Spach.), popularly recognized as “Badam Talkh kuhi”, is an endemic species of Iran. It is widely distributed in Central and West Asia, where it plays a role in preventing and controlling soil erosion. Although domestic species of Prunus genus are well known and widely used in food, pharmaceutical, and cosmetic industries, poor information about wild species is available so far. As far as Prunus lycioides, it is commonly used by native people in traditional medicine for treating diabetes, inflammatory diseases, and microbial infections. The wild almonds are traditionally exploited for oil extraction, due to their antioxidant properties. This review summarizes advances in the studies regarding of Prunus lycioides and its pharmacological properties. The aim of the review is to renew the interest in this promising plant, thus stimulating researchers to go further with the study for discovering new bioactive compounds.


2015 ◽  
Vol 14 (14) ◽  
pp. 1156-1168 ◽  
Author(s):  
Agata Koziol ◽  
Agnieszka Stryjewska ◽  
Tadeusz Librowski ◽  
Kinga Salat ◽  
Magdalena Gawel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document